SPX3,911.74+116.01 3.06%
DIA315.02+8.28 2.70%
IXIC11,607.62+375.43 3.34%

Sanofi says its COVID-19 booster shot has potential against main variants

reuters.com · 06/13/2022 01:42
Sanofi says its COVID-19 booster shot has potential against main variants

- French drugmaker Sanofi GCVRZ on Monday said the COVID-19 vaccine candidate it has developed jointly with GSK in two trials showed a potential to protect against the virus's main variants of concern, including the Omicron BA.1 and BA.2 strains, when used as a booster jab.

"Across both studies, the Sanofi-GSK next-generation vaccine candidate was well-tolerated, with a favourable safety profile," Sanofi said in a statement, adding that it would publish the complete findings of the studies later this year.


(Reporting by Tassilo Hummel; Editing by Tom Hogue)

((tassilo.hummel@thomsonreuters.com ; Twitter handle: @tassilo_hummel;))